|
www.companiesandmarkets.com: Dendreon Corporation - Corporate and
Strategic Assessment Report
(M2 PressWIRE Via Acquire Media NewsEdge)
RDATE:07102008
-www.companiesandmarkets.com adds new report: Dendreon Corporation -
Corporate and Strategic Assessment Report Company Strategy, SWOT
Analysis
Introduction
Dendreon Corporation (Dendreon) develops therapeutic vaccines to
increase a patient''s immune system to fight against diseases such as
cancer. Provenge, the company''s lead vaccine candidate, is a potential
prostate cancer therapy. In addition, it is also developing vaccines to
treat breast, colon, lung, ovarian, and kidney cancers, among others.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year
financial trends, key products and key competitors Includes information
on suppliers/ partners, shareholding structure and key employees with
biographies
Highlights
Dendreon has diversified pipeline products that include: active
cellular immunotherapy, monoclonal antibody and small molecule product
candidates to treat a wide range of cancers. The company has
collaborative partners including: Amgen, Fremont and Genentech.
Dendreon''s total revenues during the period 2002-2006 declined at a
CAGR of 63% from $15 million to $0.3 million.
Termination of agreement with Kirin Brewery and expiry of the
collaboration agreement with Johnson & Johnson Pharmaceutical research
and development are the primary reasons for the significant decrease in
revenues. During 2006-2010, Dendreon''s revenues are forecasted to grow
at a CAGR of 66% increasing from $0.3 million to $2 million, derived
primarily from the licensing granted to Wilex for small molecule
inhibitors of urokinase plasminogen activator (u-PA) in developing
products.
Reasons to Purchase
Access all the important information and analysis on the company in a
single report
Understand company''s strengths, weaknesses, opportunities and threats
along with business strategy and value chain
Gain access to company''s adjusted five year financial data along with
key ratios and market capitalization
http://www.companiesandmarkets.com/information.asp?id=2OWSQLNFH45991
CONTACT: Mike King, Director, www.companiesandmarkets.com
Tel: +44 (0)1933 674 780
Fax: +44 (0)1933 674 780
e-mail: info@companiesandmarkets.com
WWW:http://www.companiesandmarkets.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
INDUSTRIES
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO East, February 2-4, 2009. Miami, Florida.
